Cargando…
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles
[Image: see text] One of the most daunting challenges of nanomedicine is the finding of appropriate targeting agents to deliver suitable payloads precisely to cells affected by malignancies. Even more complex is the ability to ensure that the nanosystems enter those cells. Here, we use 2 nm (metal c...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247774/ https://www.ncbi.nlm.nih.gov/pubmed/27771945 http://dx.doi.org/10.1021/acs.bioconjchem.6b00441 |
_version_ | 1782497139551633408 |
---|---|
author | Jha, Satadru Ramadori, Federico Quarta, Santina Biasiolo, Alessandra Fabris, Enrica Baldan, Paola Guarino, Gaetano Ruvoletto, Mariagrazia Villano, Gianmarco Turato, Cristian Gatta, Angelo Mancin, Fabrizio Pontisso, Patrizia Scrimin, Paolo |
author_facet | Jha, Satadru Ramadori, Federico Quarta, Santina Biasiolo, Alessandra Fabris, Enrica Baldan, Paola Guarino, Gaetano Ruvoletto, Mariagrazia Villano, Gianmarco Turato, Cristian Gatta, Angelo Mancin, Fabrizio Pontisso, Patrizia Scrimin, Paolo |
author_sort | Jha, Satadru |
collection | PubMed |
description | [Image: see text] One of the most daunting challenges of nanomedicine is the finding of appropriate targeting agents to deliver suitable payloads precisely to cells affected by malignancies. Even more complex is the ability to ensure that the nanosystems enter those cells. Here, we use 2 nm (metal core) gold nanoparticles to target human hepatocellular carcinoma (HepG2) cells stably transfected with the SERPINB3 (SB3) protein. The nanoparticles were coated with a 85:15 mixture of thiols featuring, respectively, a phosphoryl choline (to ensure water solubility and biocompatibility) and a 28-mer peptide corresponding to the amino acid sequence 21–47 of the hepatitis B virus-PreS1 protein (PreS1(21–47)). Conjugation of the peptide was performed via the maleimide–thiol reaction in methanol, allowing the use of a limited amount of the targeting molecule. This is an efficient procedure also in the perspective of selecting libraries of new targeting agents. The rationale behind the selection of the peptide is that SB3, which is undetectable in normal hepatocytes, is overexpressed in hepatocellular carcinoma and in hepatoblastoma and has been proposed as a target of the hepatitis B virus (HBV). For the latter, the key recognition element is the PreS1(21–47) peptide, which is a fragment of one of the proteins composing the viral envelope. The ability of the conjugated nanoparticles to bind the target protein SB3, expressed in liver cancer cells, was investigated by surface plasmon resonance analysis and in vitro via cellular uptake analysis followed by atomic absorption analysis of digested samples. The results showed that the PreS1(21–47) peptide is a suitable targeting agent for cells overexpressing the SB3 protein. Even more important is the evidence that the gold nanoparticles are internalized by the cells. The comparison between the surface plasmon resonance analysis and the cellular uptake studies suggests that the presentation of the protein on the cell surface is critical for efficient recognition. |
format | Online Article Text |
id | pubmed-5247774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-52477742017-01-23 Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles Jha, Satadru Ramadori, Federico Quarta, Santina Biasiolo, Alessandra Fabris, Enrica Baldan, Paola Guarino, Gaetano Ruvoletto, Mariagrazia Villano, Gianmarco Turato, Cristian Gatta, Angelo Mancin, Fabrizio Pontisso, Patrizia Scrimin, Paolo Bioconjug Chem [Image: see text] One of the most daunting challenges of nanomedicine is the finding of appropriate targeting agents to deliver suitable payloads precisely to cells affected by malignancies. Even more complex is the ability to ensure that the nanosystems enter those cells. Here, we use 2 nm (metal core) gold nanoparticles to target human hepatocellular carcinoma (HepG2) cells stably transfected with the SERPINB3 (SB3) protein. The nanoparticles were coated with a 85:15 mixture of thiols featuring, respectively, a phosphoryl choline (to ensure water solubility and biocompatibility) and a 28-mer peptide corresponding to the amino acid sequence 21–47 of the hepatitis B virus-PreS1 protein (PreS1(21–47)). Conjugation of the peptide was performed via the maleimide–thiol reaction in methanol, allowing the use of a limited amount of the targeting molecule. This is an efficient procedure also in the perspective of selecting libraries of new targeting agents. The rationale behind the selection of the peptide is that SB3, which is undetectable in normal hepatocytes, is overexpressed in hepatocellular carcinoma and in hepatoblastoma and has been proposed as a target of the hepatitis B virus (HBV). For the latter, the key recognition element is the PreS1(21–47) peptide, which is a fragment of one of the proteins composing the viral envelope. The ability of the conjugated nanoparticles to bind the target protein SB3, expressed in liver cancer cells, was investigated by surface plasmon resonance analysis and in vitro via cellular uptake analysis followed by atomic absorption analysis of digested samples. The results showed that the PreS1(21–47) peptide is a suitable targeting agent for cells overexpressing the SB3 protein. Even more important is the evidence that the gold nanoparticles are internalized by the cells. The comparison between the surface plasmon resonance analysis and the cellular uptake studies suggests that the presentation of the protein on the cell surface is critical for efficient recognition. American Chemical Society 2016-10-22 2017-01-18 /pmc/articles/PMC5247774/ /pubmed/27771945 http://dx.doi.org/10.1021/acs.bioconjchem.6b00441 Text en Copyright © 2016 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Jha, Satadru Ramadori, Federico Quarta, Santina Biasiolo, Alessandra Fabris, Enrica Baldan, Paola Guarino, Gaetano Ruvoletto, Mariagrazia Villano, Gianmarco Turato, Cristian Gatta, Angelo Mancin, Fabrizio Pontisso, Patrizia Scrimin, Paolo Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles |
title | Binding and Uptake into Human Hepatocellular Carcinoma
Cells of Peptide-Functionalized Gold Nanoparticles |
title_full | Binding and Uptake into Human Hepatocellular Carcinoma
Cells of Peptide-Functionalized Gold Nanoparticles |
title_fullStr | Binding and Uptake into Human Hepatocellular Carcinoma
Cells of Peptide-Functionalized Gold Nanoparticles |
title_full_unstemmed | Binding and Uptake into Human Hepatocellular Carcinoma
Cells of Peptide-Functionalized Gold Nanoparticles |
title_short | Binding and Uptake into Human Hepatocellular Carcinoma
Cells of Peptide-Functionalized Gold Nanoparticles |
title_sort | binding and uptake into human hepatocellular carcinoma
cells of peptide-functionalized gold nanoparticles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247774/ https://www.ncbi.nlm.nih.gov/pubmed/27771945 http://dx.doi.org/10.1021/acs.bioconjchem.6b00441 |
work_keys_str_mv | AT jhasatadru bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT ramadorifederico bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT quartasantina bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT biasioloalessandra bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT fabrisenrica bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT baldanpaola bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT guarinogaetano bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT ruvolettomariagrazia bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT villanogianmarco bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT turatocristian bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT gattaangelo bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT mancinfabrizio bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT pontissopatrizia bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles AT scriminpaolo bindinganduptakeintohumanhepatocellularcarcinomacellsofpeptidefunctionalizedgoldnanoparticles |